|
|
Volumn 491, Issue 7425, 2012, Pages S58-S60
|
|
Carrying drugs
a
a
NONE
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BIND 014;
CALAA 01;
CRLX 101;
DOXORUBICIN;
NANOCARRIER;
NANOPARTICLE;
NAOPLATIN;
NK 105;
UNCLASSIFIED DRUG;
CISPLATIN;
DRUG CARRIER;
SMALL INTERFERING RNA;
ARTICLE;
CANCER CHEMOTHERAPY;
DRUG FORMULATION;
HUMAN;
NANOMEDICINE;
NANOTECHNOLOGY;
NONHUMAN;
PARTICLE SIZE;
PHASE 1 CLINICAL TRIAL (TOPIC);
PHASE 2 CLINICAL TRIAL (TOPIC);
PHASE 3 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
TUMOR MICROENVIRONMENT;
ANIMAL;
CHEMISTRY;
CLINICAL TRIAL (TOPIC);
DRUG RESISTANCE;
ENZYME SPECIFICITY;
GENETICS;
LEUKEMIA;
LOGIC;
METABOLISM;
METASTASIS;
METHODOLOGY;
NEOPLASM;
PANCREAS TUMOR;
RNA INTERFERENCE;
ROBOTICS;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CISPLATIN;
CLINICAL TRIALS AS TOPIC;
DOXORUBICIN;
DRUG CARRIERS;
DRUG RESISTANCE, NEOPLASM;
HUMANS;
LEUKEMIA;
LOGIC;
NANOMEDICINE;
NANOPARTICLES;
NEOPLASM METASTASIS;
NEOPLASMS;
PANCREATIC NEOPLASMS;
RNA INTERFERENCE;
RNA, SMALL INTERFERING;
ROBOTICS;
SUBSTRATE SPECIFICITY;
|
|
EID: 84872200994
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/491S58a Document Type: Article |
|
Times cited : (171)
|
|
References (4)
|
